NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

Richard Kim, MD

Practice Area Focus

  • Biologics
  • Drugs
  • Clinical Study Design
  • Development Strategy
  • Product Labeling/Marketing
  • Post-marketing
  • Medical Affairs
  • Expert Witness
  • Neurology


Richard Kim, MD joined NDA Partners as an Expert Consultant in 2018. He is an experienced neurologist and well-diversified pharmaceutical executive with 15-years of experience in both clinical development and medical affairs from Phase I to IV at small to mid-sized biotech and pharmaceutical companies. He has directly worked on products that are approved in the U.S. and globally, such as Tysabri, Horizant, Cladribine, Butrans, and Rebif.

Dr. Kim formerly served in senior executive roles as Chief Medical Officer and Senior Vice President of Clinical Development and Medical Affairs at XenoPort, and as Vice President, Clinical Development and Head of MS Therapeutic Area at Elan Pharmaceuticals. Prior to his position at Elan, he was the Global Medical Director, Medical Affairs at Biogen Idec; Medical Director, Clinical Development at EMD Serono, and Associate Medical Director, Clinical Pharmacology at Purdue Pharma.

Dr. Kim is an expert in a wide range of indications, including multiple sclerosis, psoriasis, restless legs syndrome, amyotrophic lateral sclerosis, alcohol use disorder, and post-herpetic neuralgia. He is board-certified by the American Board of Psychiatry and Neurology and a member of the American Academy of Neurology.